AIP
EW icon

Ameritas Investment Partners’s Edwards Lifesciences EW Stock Holding History

Ameritas Investment Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$474K Hold
5,924
– – 0.01% 855
2025
Q4 		$505K Sell
5,924
-757
-11% -$62.1K 0.02% 823
2025
Q3 		$520K Sell
6,681
-186
-3% -$14.5K 0.02% 811
2025
Q2 		$537K Sell
6,867
-240
-3% -$17.9K 0.02% 817
2025
Q1 		$515K Sell
7,107
-25
-0.4% -$1.79K 0.02% 806
2024
Q4 		$528K Sell
7,132
-355
-5% -$24.8K 0.02% 813
2024
Q3 		$494K Sell
7,487
-454
-6% -$33K 0.02% 840
2024
Q2 		$734K Sell
7,941
-279
-3% -$24.7K 0.03% 701
2024
Q1 		$786K Sell
8,220
-30,369
-79% -$2.55M 0.03% 686
2023
Q4 		$2.94M Sell
38,589
-9,084
-19% -$632K 0.11% 174
2023
Q3 		$3.3M Sell
47,673
-4,265
-8% -$343K 0.13% 133
2023
Q2 		$4.9M Sell
51,938
-4,228
-8% -$367K 0.18% 80
2023
Q1 		$4.65M Buy
56,166
+411
+0.7% +$32.3K 0.18% 86
2022
Q4 		$4.2M Sell
55,755
-1,148
-2% -$88.5K 0.17% 109
2022
Q3 		$4.7M Sell
56,903
-110
-0.2% -$10.6K 0.21% 75
2022
Q2 		$5.42M Buy
57,013
+730
+1% +$75.6K 0.23% 61
2022
Q1 		$6.63M Sell
56,283
-92
-0.2% -$10.3K 0.24% 58
2021
Q4 		$7.3M Sell
56,375
-1,139
-2% -$133K 0.25% 55
2021
Q3 		$6.51M Sell
57,514
-645
-1% -$73.6K 0.24% 57
2021
Q2 		$6.02M Sell
58,159
-1,836
-3% -$173K 0.22% 64
2021
Q1 		$5.28M Sell
59,995
-745
-1% -$63K 0.2% 71
2020
Q4 		$5.54M Sell
60,740
-787
-1% -$65.3K 0.25% 52
2020
Q3 		$4.91M Sell
61,527
-668
-1% -$52.1K 0.22% 65
2020
Q2 		$4.3M Buy
62,195
+5,459
+10% +$388K 0.2% 73
2020
Q1 		$3.57M Sell
56,736
-768
-1% -$55.4K 0.2% 72
2019
Q4 		$4.47M Sell
57,504
-13,755
-19% -$1.07M 0.2% 71
2019
Q3 		$5.22M Sell
71,259
-219
-0.3% -$15.4K 0.24% 60
2019
Q2 		$4.4M Buy
71,478
+432
+0.6% +$26.1K 0.2% 74
2019
Q1 		$4.53M Sell
71,046
-2,715
-4% -$155K 0.21% 67
2018
Q4 		$3.77M Buy
73,761
+1,251
+2% +$63.3K 0.21% 78
2018
Q3 		$4.21M Sell
72,510
-723
-1% -$35.4K 0.19% 87
2018
Q2 		$3.55M Sell
73,233
-1,044
-1% -$48.7K 0.17% 99
2018
Q1 		$3.45M Sell
74,277
-11,595
-14% -$504K 0.17% 108
2017
Q4 		$3.73M Buy
85,872
+4,626
+6% +$170K 0.17% 116
2017
Q3 		$2.98M Sell
81,246
-15,369
-16% -$586K 0.14% 139
2017
Q2 		$3.81M Sell
96,615
-1,413
-1% -$51.6K 0.18% 86
2017
Q1 		$3.07M Sell
98,028
-10,233
-9% -$320K 0.15% 127
2016
Q4 		$3.38M Buy
108,261
+23,190
+27% +$751K 0.17% 114
2016
Q3 		$3.42M Buy
85,071
+20,769
+32% +$782K 0.19% 95
2016
Q2 		$2.14M Buy
64,302
+384
+0.6% +$13.1K 0.14% 159
2016
Q1 		$1.88M Buy
63,918
+50,100
+363% +$1.38M 0.12% 178
2015
Q4 		$363K Sell
13,818
-930
-6% -$24.2K 0.02% 718
2015
Q3 		$349K Hold
14,748
– – 0.03% 706
2015
Q2 		$350K Buy
14,748
+3,072
+26% +$69.3K 0.02% 752
2015
Q1 		$277K Hold
11,676
– – 0.02% 865
2014
Q4 		$248K Buy
+11,676
New +$235K 0.02% 900
2013
Q3 		– Sell
-90,864
Closed -$1.02M – 1013
2013
Q2 		$1.02M Buy
+90,864
New +$1.08M 0.28% 154

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ameritas Investment Partners's EW Position: Q1 2026 in Review

Ameritas Investment Partners held its Edwards Lifesciences (EW) position steady in Q1 2026 at 5,924 shares worth $474K. The position accounts for 0.01% of the portfolio, ranked #855.

Ameritas Investment Partners first reported a position in EW in Q2 2013 and has held it in 47 quarters since. The position peaked at $7.3M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Ameritas Investment Partners held 5,924 shares of Edwards Lifesciences worth $474K as of Q1 2026.
  • Ameritas Investment Partners left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #855 holding.
  • Ameritas Investment Partners first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 47 quarters since.
  • Ameritas Investment Partners's Edwards Lifesciences position peaked at $7.3M in Q4 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.